Declan J. McKenna

903 total citations
37 papers, 696 citations indexed

About

Declan J. McKenna is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Declan J. McKenna has authored 37 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Declan J. McKenna's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Prostate Cancer Treatment and Research (7 papers). Declan J. McKenna is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Prostate Cancer Treatment and Research (7 papers). Declan J. McKenna collaborates with scholars based in United Kingdom, United States and Ireland. Declan J. McKenna's co-authors include D. Patel, Stephanie McKeown, Dennis J. McCance, Colum P. Walsh, Ian Rowland, Patricia Heavey, Valerie J. McKelvey‐Martin, Simon S. McDade, Christopher J. McNally and Alan W. Stitt and has published in prestigious journals such as PLoS ONE, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Declan J. McKenna

37 papers receiving 680 citations

Peers

Declan J. McKenna
Feihu Bai China
Yunxia Ma China
Yan-qing Ding China
Libin Sun China
Qiumeng Liu China
Hongyan Zhang China
Ľ Danihel Slovakia
Yongping Cui China
Feihu Bai China
Declan J. McKenna
Citations per year, relative to Declan J. McKenna Declan J. McKenna (= 1×) peers Feihu Bai

Countries citing papers authored by Declan J. McKenna

Since Specialization
Citations

This map shows the geographic impact of Declan J. McKenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Declan J. McKenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Declan J. McKenna more than expected).

Fields of papers citing papers by Declan J. McKenna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Declan J. McKenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Declan J. McKenna. The network helps show where Declan J. McKenna may publish in the future.

Co-authorship network of co-authors of Declan J. McKenna

This figure shows the co-authorship network connecting the top 25 collaborators of Declan J. McKenna. A scholar is included among the top collaborators of Declan J. McKenna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Declan J. McKenna. Declan J. McKenna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willoughby, Colin E., et al.. (2024). The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p. International Journal of Molecular Sciences. 25(8). 4301–4301. 5 indexed citations
2.
Simpson, David, et al.. (2024). The TGFβ Induced MicroRNAome of the Trabecular Meshwork. Cells. 13(12). 1060–1060. 3 indexed citations
3.
Willoughby, Colin E., et al.. (2023). Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer. Cells. 12(18). 2207–2207. 6 indexed citations
4.
McKenna, Declan J., et al.. (2023). MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF. International Journal of Molecular Sciences. 24(3). 1824–1824. 12 indexed citations
5.
McNally, Christopher J., et al.. (2023). MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. Cancers. 15(4). 1291–1291. 14 indexed citations
6.
Downing, Tim, et al.. (2022). Data pertaining to aberrant intracellular calcium handling during androgen deprivation therapy in prostate cancer. Data in Brief. 42. 108143–108143. 1 indexed citations
7.
Downing, Tim, et al.. (2022). CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer. Cell Calcium. 103. 102554–102554. 14 indexed citations
8.
McNally, Christopher J., Mark W. Ruddock, Tara Moore, & Declan J. McKenna. (2020). <p>Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review</p>. Cancer Management and Research. Volume 12. 5225–5241. 46 indexed citations
9.
Iguacel, Isabel, Amy Mullee, Neela Guha, et al.. (2019). Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis. Prostate Cancer and Prostatic Diseases. 23(1). 11–23. 9 indexed citations
10.
Ward, Mary, Helene McNulty, Geraldine Horigan, et al.. (2019). Serum levels of miR-199a-5p correlates with blood pressure in premature cardiovascular disease patients homozygous for the MTHFR 677C > T polymorphism. Genomics. 112(1). 669–676. 11 indexed citations
11.
Ward, Mary, Helene McNulty, Geraldine Horigan, et al.. (2017). miR-199a-5p is a marker of blood pressure in premature cardiovascular disease patients homozygous for the MTHFR C677T polymorphism.. Journal of Human Hypertension. 31. 1 indexed citations
12.
Nesbitt, Heather, Niall M. Byrne, Jenny Worthington, et al.. (2016). Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression. Clinical Cancer Research. 23(7). 1797–1808. 23 indexed citations
13.
Nesbitt, Heather, Niall J. Byrne, Jenny Worthington, et al.. (2016). Targeting hypoxic prostate tumours using the novel hypoxia-activated prodrug OCT1002 inhibits expression of genes associated with malignant progression. Ulster University Research Portal (Ulster University). 86(1). 11–11. 1 indexed citations
14.
Nesbitt, Heather, Gillian Browne, Niall M. Byrne, et al.. (2015). Nitric Oxide Up‐Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo. Journal of Cellular Physiology. 231(2). 473–482. 16 indexed citations
15.
McKenna, Declan J., D. Patel, & Dennis J. McCance. (2013). miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes. Virology. 448. 210–216. 25 indexed citations
16.
McKenna, Declan J., et al.. (2012). Use of the Comet-FISH Assay to Compare DNA Damage and Repair in p53 and hTERT Genes following Ionizing Radiation. PLoS ONE. 7(11). e49364–e49364. 15 indexed citations
17.
Watson, Jenny, Declan J. McKenna, Perry Maxwell, et al.. (2009). Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. Journal of Cellular and Molecular Medicine. 14(6b). 1668–1682. 14 indexed citations
18.
19.
McKenna, Declan J., Nor Fadilah Rajab, Stephanie McKeown, George McKerr, & Valerie J. McKelvey‐Martin. (2003). Use of the Comet-FISH Assay to Demonstrate Repair of theTP53Gene Region in Two Human Bladder Carcinoma Cell Lines. Radiation Research. 159(1). 49–56. 32 indexed citations
20.
McKenna, Declan J., et al.. (2000). The Expression of Membrane-Associated 67-kDa Laminin Receptor (67LR) Is Modulated in Vitro by Cell-Contact Inhibition. PubMed. 3(1). 53–59. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feihu Bai Breakdown of academic impact, for papers by Yunxia Ma Breakdown of academic impact, for papers by Yan-qing Ding Breakdown of academic impact, for papers by Libin Sun Breakdown of academic impact, for papers by Qiumeng Liu Breakdown of academic impact, for papers by Hongyan Zhang Breakdown of academic impact, for papers by Ľ Danihel Breakdown of academic impact, for papers by Yongping Cui
Rankless by CCL
2026